维特波芬是一种有效的HCMV复制抑制剂
Woo Young Lim1, Ju Hyun Lee1, Youngju Choi2
1Department of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, South Korea.
Virus research
|October 3, 2024
概括
美国食品和药物管理局 (FDA) 批准的药物维特波芬有效地抑制了人类细胞巨乳病毒 (HCMV) 复制. 这项研究表明,甲作为一种潜在的重用抗病毒疗法,用于HCMV感染.
科学领域:
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
- 药物重用 药物重用
背景情况:
- 人类细胞巨乳病毒 (HCMV) 对新生儿和免疫功能低下的人构成重大风险.
- 冠状病毒感染可能导致严重的神经发育障碍.
研究的目的:
- 通过药物重新定位来识别FDA批准的用于抑制HCMV复制的药物.
- 为了评估甲状腺素对HCMV的疗效.
主要方法:
- 利用HCMV后代测试来选抗病毒活性.
- 研究了甲的作用机制,包括对病毒进入和核运输的影响.
- 在整个HCMV生命周期中量化病毒mRNA和蛋白质水平.
主要成果:
- 韦尔特芬证明了剂量依赖性抑制HCMV的产生,显著减少了0.5μM的复制.
- 甲并不妨碍HCMV宿主细胞的进入或核运输.
- 该药物从HCMV生命周期的直接早期阶段降低了病毒mRNA和蛋白质水平.
结论:
- 维特波芬对HCMV具有强大的抗病毒活性.
- 维特波芬的机制涉及抑制病毒基因表达和蛋白质生产.
- 甲显示出迅速和安全的发展作为一个重用药物对HCMV感染的承诺.
相关概念视频
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...